Dr Bilal Bawamia
Dr Luke Spray
Vincent Wangsaputra
Dr Karim Bennaceur
Dr Sharareh Vahabi
et al. | Activation of telomerase by TA-65 enhances immunity and reduces inflammation post myocardial infarction Randomized Pilot Trial | 2023 |
|
Dr Ayman Al-atta
Dr Luke Spray
Dr Ashfaq Mohammed
Professor Ioakim Spyridopoulos
| Arginine Vasopressin Plays a Role in Microvascular Dysfunction After ST-Elevation Myocardial Infarction | 2023 |
|
Dr Kateryna Sopova
Dr Simon Tual-Chalot
Dr Nikolaos Vlachogiannis
Dr Georgios Georgiopoulos
Dr Luke Spray
et al. | Effector T cell chemokine IP-10 predicts cardiac recovery and clinical outcomes post-myocardial infarction | 2023 |
|
Shu Xian Loh
Yasemin Ekinci
Dr Luke Spray
Dr Visvesh Jeyalan
Professor Gavin Richardson
et al. | Fractalkine Signalling (CX3CL1/CX3CR1 Axis) as an Emerging Target in Coronary Artery Disease. | 2023 |
|
Dr Georgios Georgiopoulos
Dr Kateryna Sopova
Dr Luke Spray
Dr Jose Coelho Lima Junior
Dr Simon Tual-Chalot
et al. | Modification of the GRACE Risk Score for Risk Prediction in Patients with Acute Coronary Syndromes | 2023 |
|
Jose Coelho Lima Junior
Dr Georgios Georgiopoulos
Dr Jannath Ahmed
David Gaskin
Dr Konstantinos Bakogiannis
et al. | Prognostic value of admission high-sensitivity troponin in patients with ST-elevation myocardial infarction | 2021 |
|
Dr Sarah Marsh
Dr Catherine Park
Dr Rachael Redgrave
Dr Esha Singh
Lilia Draganova
et al. | Rapid fall in circulating non-classical monocytes in ST elevation myocardial infarction patients correlates with cardiac injury | 2021 |
|
Dr Luke Spray
Dr Catherine Park
Dr Suzanne Cormack
Dr Ashfaq Mohammed
Dr Stephen Boag
et al. | The Fractalkine Receptor CX3CR1 Links Lymphocyte Kinetics in CMV-Seropositive Patients and Acute Myocardial Infarction With Adverse Left Ventricular Remodeling | 2021 |
|
